Reps. Maxwell Frost (D-FL) and Doris Matsui (D-CA) have introduced a bill to Congress called the “Epinephrine’s Pharma Inflated Price Ends Now Act,” also called the “EPIPEN Act” (H.R.6965). It is a bill that would cap the out-of-pocket costs for all brands of epinephrine auto-injectors to $60 per two-pack. This bill would apply to people with private insurance. Private insurance includes plans through an employer or individually purchased health insurance.

The EPIPEN Act addresses the high costs of epinephrine auto-injectors millions of people rely on. It would also increase access to the potentially lifesaving medicine.

Epinephrine is the first-line treatment for anaphylaxis, a severe allergic reaction. Some of the most common causes of anaphylaxis, a severe allergic reaction are:

• Foods
• Drugs
• Latex
• Venom from stinging and biting insects

Anaphylaxis can have life-threatening complications. It is critical that people have access to epinephrine. Quick use of epinephrine can stop the allergic reaction.

The rising cost of epinephrine auto-injectors is hard on families managing food and other allergies. The increasing prices of these devices, including generics, have made it harder for many people to have access to auto-injectors.

The EPIPEN Act will make a big difference in the lives of many people and their families. It helps ensure people get the crucial medicine they need.

Will you help the Asthma and Allergy Foundation of America (AAFA) and Kids with Food Allergies (KFA) gather support for this bill in Congress? You can ask your congressperson to support the EPIPEN Act using the form below. You can also edit the letter to include your own story about getting epinephrine auto-injectors.